<DOC>
	<DOCNO>NCT00539799</DOCNO>
	<brief_summary>There debate whether long-term low-dose steroid prednisolone help suppress relapse systemic lupus erythematosus ( SLE ) patient remission lupus nephritis . If low-dose prednisolone reduces relapse , beneficial effect may counter-balanced long-term side-effects associate prednisolone . This pilot study determine feasibility conduct large randomize control trial answer question whether long-term low-dose prednisolone ( 5 - 7.5 mg/day ) reduce flare SLE patient previous lupus nephritis .</brief_summary>
	<brief_title>Steroids Maintenance Remission Proliferative Lupus Nephritis</brief_title>
	<detailed_description />
	<mesh_term>Nephritis</mesh_term>
	<mesh_term>Lupus Nephritis</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>age least 18 year diagnosis SLE ACR criterion diagnosis proliferative lupus nephritis ( ISN/RPS class III IV ) currently prednisolone ( 5 20 mg/day ) partial complete remission least 3 month currently pregnant endstage renal failure receive corticosteroid indication lupus nephritis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>systemic lupus erythematosus</keyword>
	<keyword>lupus nephritis</keyword>
</DOC>